Zoetis Inc.

ZTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $864.0M $821.0M $339.0M $583.0M $504.0M $436.0M $245.0M
Depreciation & Amortization $242.0M $240.0M $199.0M $204.0M $209.0M $200.0M $205.0M
Depreciation $142.0M $145.0M $135.0M $141.0M $146.0M $133.0M $135.0M
Amortization $100.0M $95.0M $64.0M $63.0M $63.0M $67.0M $70.0M
Stock-Based Compensation $44.0M $37.0M $43.0M $32.0M $43.0M $28.0M $19.0M
Net Cash from Operating Activities $1.35B $713.0M $664.0M $626.0M $681.0M $454.0M $497.0M
Investing Activities
Capital Expenditures $224.0M $216.0M $224.0M $180.0M $184.0M $126.0M $135.0M
Business Acquisitions $0 $88.0M $883.0M $0 $0 $0 $345.0M
Net Cash from Investing Activities $-270.0M $-214.0M $-1.12B $-187.0M $-179.0M $-135.0M $-449.0M
Financing Activities
Dividends Paid
Stock Repurchases $500.0M $300.0M $203.0M $0 $0
Net Cash from Financing Activities $-251.0M $-903.0M $755.0M $-154.0M $-200.0M $-78.0M $-30.0M
Net Change in Cash $837.0M $-427.0M $272.0M $272.0M $293.0M $238.0M $16.0M
Free Cash Flow $1.12B $497.0M $440.0M $446.0M $497.0M $328.0M $362.0M
← Newer Page 2 of 2 Older →